New antibody-toxin conjugate designed to stimulate immune-mediated eradication of tumors

Researchers at The University of Texas MD Anderson Cancer Center have developed a novel antibody-toxin conjugate (ATC) designed to stimulate immune-mediated eradication of tumors.

Common Drugs, Vaccines Tied to Less Dementia Risk; New LATE Criteria; Rethinking ALS

Antimicrobials, vaccinations, and anti-inflammatory drugs were associated with a reduced risk of dementia in a systematic review, while diabetes drugs, vitamins and supplements, and antipsychotics

January 22, 2025

Futureproofing supply chains in an evolving pharmaceutical industry – Pharmaceutical Technology

Pharmaceutical supply chains are some of the world’s most intricate. Recent developments have only heightened the challenges for companies on the receiving end of them.

October 24, 2024

How primary care is being disrupted: A video primer

How patients are seeing their doctor is changing, and that could shape access to and quality of care for decades to come.

April 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.